Evidence map›Paper›PMID 8898363›Full record

ArticleMolecular biology of the cell1996

Characterization of novel mutations at the Schizosaccharomyces pombe cdc2 regulatory phosphorylation site, tyrosine 15.

K L Gould, A Feoktistova

Open access · greenAbstract readComparative Study
In one paragraph

Article in Molecular biology of the cell, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Consequences of abnormal CDK activity in S phase.Cell cycle (Georgetown, Tex.) · 2016
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

K L GouldHoward Hughes Medical Institute, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
A Feoktistova
Howard Hughes Medical Institute · US

Funding

MECHANISMS OF EUKARYOTIC CELL CYCLE CONTROLR01GM047728 · NIGMS · VANDERBILT UNIVERSITY · PI GOULD, KATHLEEN L · 1992 to 2004
$989k
NIGMS NIH HHS GM-47728
6 · The paper itself

Abstract

The cdc2 protein kinase family is regulated negatively by phosphorylation in the glycine ATP-binding loop at a conserved tyrosine residue, Y15, alone or in combination with T14 phosphorylation. In Schizosaccharomyces pombe and other systems, substitution of these residues with structurally similar but nonphosphorylatable amino acids has generated proteins (Y15F or T14AY15F) that behave as constitutively tyrosine-dephosphorylated proteins or threonine and tyrosine-dephosphorylated proteins. Here we report the characteristics of three additional mutants at Y15--Y15E, Y15S, and Y15T--in S. pombe cdc2p. All three mutant proteins are active in in vitro kinase assays, but are unable to functionally complement cdc2 loss-of-function mutations in vivo. Additionally, all three mutants are dominant negatives. A more detailed analysis of the Y15T mutant indicates that it can initiate chromosome condensation and F-actin contractile ring formation, but is unable to drive the reorganization of microtubules into a mitotic spindle.

Indexed as

Cell Cycle ProteinsNuclear ProteinsSchizosaccharomyces pombe ProteinsCDC2 Protein KinaseCell CycleFungal ProteinsGenetic Complementation TestMicrotubulesMutagenesis, Site-DirectedPhosphorylationPhosphotyrosineProtein KinasesProtein Processing, Post-TranslationalProtein-Tyrosine KinasesRecombinant Fusion ProteinsSchizosaccharomycesCDC2 Protein KinaseCell Cycle ProteinsFungal Proteinshistone H1 kinasemik1 protein, S pombeNuclear ProteinsPhosphotyrosineProtein KinasesProtein-Tyrosine KinasesRecombinant Fusion ProteinsSchizosaccharomyces pombe ProteinsTyrosinewee1 protein, S pombe

Identifiers

PMID8898363
PMCPMC276007
OpenAlexW2101045598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.